ArticleACS medicinal chemistry letters2022

Tricyclic Carboxamide Derivatives as PRMT5 Inhibitors for Treating Cancer.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.